Promoter shareholding decreased by 2.59% YoY, while sector averages remained stable; indicates weak insider confidence.

Public shareholding also declined by 0.53% YoY, aligning with the overall trend of selling within the stock.

No institutional buying activity suggests lack of interest from smart money, further confirming the selling pressure on Morepen Laboratories.